Peg-aspargase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peg-aspargase, covering 2022-06-09 to 2022-06-09. Get the full timeline:
Most recent: Clinical Trial Update: Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma [Phase 2]